1. Home
  2. STTK vs TWIN Comparison

STTK vs TWIN Comparison

Compare STTK & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.80

Market Cap

683.8M

Sector

Health Care

ML Signal

HOLD

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

N/A

Current Price

$22.94

Market Cap

320.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
STTK
TWIN
Founded
2016
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
683.8M
320.9M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
STTK
TWIN
Price
$7.80
$22.94
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
828.7K
87.2K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
0.98%
EPS Growth
53.02
N/A
EPS
N/A
1.76
Revenue
$1,000,000.00
$340,738,000.00
Revenue This Year
N/A
$10.79
Revenue Next Year
N/A
$8.43
P/E Ratio
N/A
$13.31
Revenue Growth
N/A
15.45
52 Week Low
$0.92
$12.00
52 Week High
$8.33
$25.50

Technical Indicators

Market Signals
Indicator
STTK
TWIN
Relative Strength Index (RSI) 57.57 49.03
Support Level $5.87 $21.57
Resistance Level $7.75 $24.28
Average True Range (ATR) 0.42 1.23
MACD -0.01 -0.15
Stochastic Oscillator 75.25 37.31

Price Performance

Historical Comparison
STTK
TWIN

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: